IDA Business & Technology Park, Parkmore West, Galway . Ireland
+ 353 87 434 3893
saving lives through early cancer detection
blood-based test kit
early colon cancer detection in blood.
is non-invasive and affordable.
also precancerous lesions
they turn into
tumours (higher sensitivity for the detection of advanced adenomas than any
competitor including FIT, Epi procolon® and Cologuard®), increasing life
expectancy and reducing health cost in procedures and treatment.
Standard laboratory equipment and procedures required to use the kits.
20B€ in USA and EU (200M people recommended for screening);
Pancreas and lung cancer kits in development
is a biotechnology company focused on early cancer detection in blood through
WO granted, others pending
Tested in humans?
clinical validation done
in process, expected for Q1 – 2021
in process, expected for Q2 – 2019
Exp. EU and US in 2019 as a service through the Lab Developed Test license
links of interest